Location History:
- Dorking, EN (1976)
- Betchworth, GB (1990)
- Dorking, GB (1978 - 2001)
Company Filing History:
Years Active: 1976-2001
Title: **The Innovative Contributions of Martin Cole in Antibacterial Research**
Introduction
Martin Cole, based in Dorking, GB, is a prolific inventor known for his significant contributions to the field of antibacterial research. With a remarkable portfolio of 27 patents, his innovations have made a considerable impact in pharmaceutical science, particularly in the development of new antibacterial agents.
Latest Patents
Among his latest patents is a groundbreaking invention related to pharmaceutical compositions featuring a newly isolated antibacterial agent called clavulanic acid. This innovative compound, derived from the bacterium Streptomyces clavuligerus, is distinguished by its formula and has displayed broad-spectrum antibiotic properties. Clavulanic acid, along with its salts and esters, is noted not only for its medium potency but also for its ability to enhance the efficacy of β-lactam antibiotics, especially against bacteria producing β-lactamase enzymes.
Career Highlights
Martin Cole has had a notable career, with significant associations with major companies in the pharmaceutical industry, including Beecham Group Plc and SmithKline Beecham Corporation. His expertise and focus on antibacterial research have led to substantial advancements in the field, contributing to the creation of essential medication for combating resistant bacteria.
Collaborations
Throughout his career, Martin has collaborated with esteemed professionals like Thomas T Howarth and Christopher Reading. These partnerships have further facilitated the development of his groundbreaking patents and innovations in antibacterial compositions.
Conclusion
Martin Cole's dedication to research and innovation has established him as a prominent figure in the realm of antibacterial agents. His patents have not only contributed to scientific knowledge but also played a vital role in the development of treatments that address critical public health issues. As the landscape of antibiotic resistance evolves, Cole's work remains instrumental in pioneering effective solutions in the fight against bacterial infections.